Autoimmune hepatitis natural history, complications and prognosis
Autoimmune hepatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Autoimmune hepatitis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Autoimmune hepatitis natural history, complications and prognosis |
FDA on Autoimmune hepatitis natural history, complications and prognosis |
CDC on Autoimmune hepatitis natural history, complications and prognosis |
Autoimmune hepatitis natural history, complications and prognosis in the news |
Blogs on Autoimmune hepatitis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]
Overview
Natural History=
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
Common complications of Autoimmune hepatitis include:
- Cirrhosis and complications of cirrhosis
- Ascites
- Coagulopathy
- Liver failure
- Hepatocellular carcinoma
- Hepatic encephalopathy
- Portal hypertension
- Esophageal varices
- Metabolic bone disease
- Hyperlipidaemia
- Hypovitaminosis of cholestasis
- Pruritis of cholestasis
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis